JCR 2024 Program
Home
> Scientific Program > JCR 2024 Program
Robert Patrick Giugliano (Brigham and Women's Hospital, USA | Harvard Medical School, USA)
| Session / Date | Room | Role | Time | Title |
|---|---|---|---|---|
|
3. Update of ACS/PCI 2024-12-13 13:30 ~ 14:50 |
Room A | Chair | - | - |
|
3. Update of ACS/PCI 2024-12-13 13:30 ~ 14:50 |
Room A | Speaker | 13:30-13:45 | Latest ACS / PCI Guidelines |
|
34. The Symposium of Atherosclerosis and Cardiovascular Intervention Research Institute 2024-12-13 17:10 ~ 18:30 |
Room A | Speaker | 17:50-18:10 | 40th Anniversary of the TIMI trials |
|
17. Morning Session 2: CV Disease Update 2024-12-14 08:00 ~ 09:00 |
Room B | Speaker | 08:35-08:50 | Update on Factor Xa and XI inhibitors |
|
38. Sponsored Scientific Luncheon: LDL-C Lowering with PCSK9 Inhibitors: From Acute to Lifelong Management in ACS (Sponsored by Amgen) 2024-12-14 12:30 ~ 13:30 |
Room A | Speaker | 12:30-12:50 | Why Choose Evolocumab for ASCVD: Clinical Benefits for Patients |
|
21. Future Cardiology and Cardio-Metabolics 2024-12-14 15:20 ~ 16:50 |
Room B | Chair | - | - |